A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
Hatzis, Christos
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. [electronic resource] - JAMA May 2011 - 1873-81 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-3598
10.1001/jama.2011.593 doi
Adult
Algorithms
Anthracyclines--therapeutic use
Antineoplastic Agents, Hormonal--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biopsy, Needle
Breast Neoplasms--drug therapy
Bridged-Ring Compounds--therapeutic use
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Forecasting
Gene Expression Profiling
Genes, Neoplasm--genetics
Genes, erbB-2
Genomics
Humans
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Oligonucleotide Array Sequence Analysis
Predictive Value of Tests
Prognosis
Prospective Studies
Receptors, Estrogen--analysis
Risk
Taxoids--therapeutic use
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. [electronic resource] - JAMA May 2011 - 1873-81 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1538-3598
10.1001/jama.2011.593 doi
Adult
Algorithms
Anthracyclines--therapeutic use
Antineoplastic Agents, Hormonal--pharmacology
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biopsy, Needle
Breast Neoplasms--drug therapy
Bridged-Ring Compounds--therapeutic use
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Forecasting
Gene Expression Profiling
Genes, Neoplasm--genetics
Genes, erbB-2
Genomics
Humans
Middle Aged
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Oligonucleotide Array Sequence Analysis
Predictive Value of Tests
Prognosis
Prospective Studies
Receptors, Estrogen--analysis
Risk
Taxoids--therapeutic use